SynCore Biotechnology Co

SynCore Biotechnology Co EPS

The Earnings per Share (EPS) of SynCore Biotechnology Co (4192.TWO) as of Nov 17, 2026 is -1.29 TWD. In the previous year, Earnings per Share (EPS) was -1.53 TWD — a change of -15.71% (higher).

EPS

-1.29TWD

YoY

-15.71%

Last updated:

Earnings per Share (EPS) of SynCore Biotechnology Co is 2025 -1.29 TWD. Earnings per Share (EPS) of SynCore Biotechnology Co was 2024 -1.53 TWD. It decreases by -15.71% higher compared to the previous year.

The SynCore Biotechnology Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-8.28 TWD
Jan 1, 2019
-4.20 TWD
Jan 1, 2020
-3.74 TWD
Jan 1, 2021
-3.99 TWD
Jan 1, 2022
-1.64 TWD
Jan 1, 2023
-1.14 TWD
Jan 1, 2024
-1.53 TWD
Jan 1, 2025
-1.29 TWD
The SynCore Biotechnology Co EPS history
YEAREPSYoY
-1.29TWD-15.71%
-1.53TWD+34.64%
-1.14TWD-30.76%
-1.64TWD-58.86%
-3.99TWD+6.47%
-3.74TWD-10.81%
-4.20TWD-49.32%
-8.28TWD+14.01%
-7.26TWD+59.02%
-4.57TWD-10.93%
-5.13TWD-67.92%
-15.99TWD+96.35%
-8.14TWD-25.93%
-10.99TWD+23.05%
-8.93TWD-49.29%
-17.62TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SynCore Biotechnology Co Stock analysis

What does SynCore Biotechnology Co do? SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan. SynCore Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SynCore Biotechnology Co stock

Earnings per Share (EPS) of SynCore Biotechnology Co is -1.29 TWD in 2025.

Earnings per Share (EPS) of SynCore Biotechnology Co changed from -1.53 TWD to -1.29 TWD, representing a -15.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) SynCore Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — SynCore Biotechnology Co

All Key Metrics — SynCore Biotechnology Co